Trimethoprim-sulfamethoxazole-graded challenge in HIV-infected patients: Long-term follow-up regarding efficacy and safety

Journal of Allergy and Clinical Immunology

Volumn 105, Issue 3, 2000, Pages 588-589

  Demoly, Pascal ^a   Messaad, Djamel ^a   Reynes, Jacques ^b   Faucherre, Vincent ^c   Bousquet, Jean ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CETIRIZINE; COTRIMOXAZOLE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROVOCATION TEST;

EID: 0034110025     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.104781     Document Type: Article

References (5)

1. 1. Ioannidis JPA, Cappeleri JC, Skolnik PR, Lau J, Sacks HS. A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens. Arch Intern Med 1996;156:177-88.
2. 2. Coopman SA, Johnson RA, Platt R, Stem RS. Cutaneous disease and drag reactions in HIV infection. N Engl J Med 1993;328:1670-4.
3. 3. Al-Sadr WM, Murphy RL, McCabe Yurik T, et al. Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients wit HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. N Engl J Med 1998;339:1889-95.
4. 4. Demoly P, Messaad D, Sahla H, et al. Six-hour trimethoprim-sulfamethoxazole graded challenge in HIV-infected patients. J Allergy Clin Immunol 1998;102:1033-6.
5. 5. Caumes E, Guermonprez G, Katlama C, Bricaire F. A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus. Clin Infect Dis 1996;23:1313-4.